NewKerala.com

Key Points

The Tata Memorial Centre has signed a landmark partnership with Wipro GE Healthcare to establish a cutting-edge Cancer Research & Innovation Centre. This collaboration aims to leverage advanced AI technologies and digital platforms to transform personalized cancer care. With India facing rising cancer incidence, the partnership seeks to enhance early detection and develop precision-driven solutions. The joint initiative represents a significant step in addressing critical challenges in cancer research and treatment.

Key Points: Tata Memorial Centre Joins Wipro GE in Cancer Research Hub

  • Collaboration establishes advanced Cancer Research & Innovation Centre
  • Partnership targets precision-driven AI cancer solutions
  • Aims to address early detection and equitable cancer care
  • Focuses on integrating imaging technologies and digital platforms
3 min read

Tata Memorial Centre signs MoU with Wipro GE Healthcare to establish 'cancer research & innovation centre'

Groundbreaking partnership between TMC and Wipro GE Healthcare aims to revolutionize cancer research using AI and advanced technologies

"We aim to enhance clinical research and promote academic engagement to transform personalized cancer care - Dr. CS Pramesh, TMC Director"

Bengaluru, June 5

Tata Memorial Centre (TMC), a grant-in-aid institution under the jurisdiction of Department of Atomic Energy, Government of India, signed a Memorandum of Understanding (MoU) with Wipro GE Healthcare Pvt. Ltd. on Wednesday, to establish a state-of-the-art Cancer Research & Innovation Centre with Wipro GE Healthcare as the technology partner and TMC as the clinical oncology partner.

Bengaluru (Karnataka) [India], June 5 (ANI): Tata Memorial Centre (TMC), a grant-in-aid institution under the jurisdiction of Department of Atomic Energy, Government of India, signed a Memorandum of Understanding (MoU) with Wipro GE Healthcare Pvt. Ltd. on Wednesday, to establish a state-of-the-art Cancer Research & Innovation Centre with Wipro GE Healthcare as the technology partner and TMC as the clinical oncology partner.

The collaboration aims to strengthen clinical research and academic engagement activities with the establishment of a 'Joint Working Group', to determine key project areas and collaboration roadmap for the next five years.

In India, around 100 out of every 1 lakh people are diagnosed with cancer1 and a report from the Cancer Registry Program states the incidence of cancer cases is estimated to increase by 12.8 per cent in 2025 as compared to 20202. The alarming statistics underscore the need for precision-driven, AI-enabled solutions to advance cancer care.

Dr CS Pramesh, Director of Tata Memorial Hospital says, "The government is adopting a strategic, policy-driven approach to fight cancer with the establishment of day care centres, expansion of cancer care ecosystem, promoting cancer screenings and awareness programmes. However, early detection, equitable access and preventive care remain a challenge."

He added, "GE HealthCare is a world leader in MedTech and as partners, we aim to enhance clinical research and promote academic engagement to transform personalized cancer care for improved outcomes cancer care."

Chaitanya Sarawate, Managing Director, Wipro GE Healthcare South Asia, says, "In India, the estimated number of incidences of cancer cases was more than 14 lakhs in 2023.3 Our innovations enable precision-led cancer care through an ecosystem of devices and digital solutions powered by AI."

He added, "We are proud to partner with industry leaders like Tata Memorial Centre, who are among the pioneers in the fight against cancer with their expertise in research, service and education. With this partnership, we strengthen our commitment to connect every step of cancer care right from discovery, diagnosis to treatment, integrating advanced imaging technologies and AI-led solutions in the care continuum."

The partnership aims to accelerate the development and validation of emerging technologies and digital platforms in Oncology - on AI-based applications for medical imaging, clinical workflows, hardware and software for advanced-visualization to post-process and analyse medical images.

The scope also includes vetted data annotations for application-development, enterprise applications for health informatics and management to drive optimization and transform personalized cancer care for improved outcomes.

- ANI

Share this article:

Reader Comments

R
Rajesh K.
This is fantastic news! Cancer cases are rising at an alarming rate in India and we need more such collaborations between healthcare and tech giants. Tata Memorial has always been at the forefront of cancer care. Hope this brings affordable treatment options soon 🙏
P
Priya M.
While this partnership is commendable, I hope they focus on making these technologies accessible beyond metro cities. My uncle had to travel from Jaipur to Mumbai for cancer treatment because local hospitals lacked facilities. Tier 2/3 cities need this more!
A
Arjun S.
Great initiative! But I'm concerned about data privacy with AI solutions. Hope they implement strong safeguards for patient medical data. Also, will this research benefit only private hospitals or government cancer centers too?
S
Sunita R.
As someone who lost a family member to cancer, this gives me hope. The stats mentioned are terrifying - 14 lakh cases in 2023! Early detection through AI could save so many lives. Kudos to both organizations for this partnership 🇮🇳
V
Vikram J.
Good step, but what about prevention? We need equal focus on awareness about tobacco, pollution and lifestyle factors causing cancer. Research is important, but prevention is cheaper than cure. Maybe they can allocate some funds for public awareness campaigns?
N
Neha P.
My mother is a cancer survivor thanks to Tata Memorial. Their work is truly commendable. Combining their expertise with GE's tech might could be game-changing! Hope this leads to more affordable treatment options soon 🤞

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50